For the purpose of the database, patent families are grouped by number (e.g., Family 1, 5, 30, etc.)
JAMA Intern
How to Think About Better Whether one of these medications will be better for you depends on your goals and your individual reaction to them
Not all GLP-1s are approved for obesity treatment, and this analysis includes all FDA-approved GLP-1s, including those approved for obesity (Saxenda, Weogvy, Zepbound) as well as those approved for type 2 diabetes (see Table 1)
Constipation and Bloating: As tirzepatide slows down the entire digestive tract, some individuals experience a noticeable slowdown in bowel movements, leading to gas or mild abdominal bloating
Even small increases in daily movement raise total calorie burn and often break slow patches